Chaff flower

Chaff Flower (Achyranthes aspera L.): A Comprehensive Reference

1. Identity and Botanical Description

1.1 Nomenclature and Taxonomy

Achyranthes aspera L. (common names: chaff-flower, prickly chaff flower, devil's horsewhip; Sanskrit: apāmārga) is a species of plant in the family Amaranthaceae. The genus name Achyranthes is derived from the Greek achyron (chaff) and anthos (flower), referring to the chaffy parts of the flower. The species epithet aspera is Latin for "rough," reflecting the plant's characteristically hairy texture.

Known as Apamarga in Ayurveda, it is a highly valued medicinal plant used across traditional healing systems. The plant carries a wide variety of vernacular names worldwide: in English it is known as chaff-flower and prickly chaff flower; in French as Achyranth à feuilles rudes, collant, and gendarme; in Spanish as mosotillo, rabo de gato, and rabo de ratón. Within the Indian subcontinent, it is known by many regional names: in Hindi as Puthkanda, Latjira, and Chirchira; in Marathi as Aghada; in Sanskrit as Apamargah; in Punjabi as Kutri; in Kannada as Gorwiballi and Karihambu; in Tamil as Naaiyuruvi; and in Telugu as Uttaraene.

1.2 Morphology and Habitat

A. aspera is a much-branched, herbaceous annual or perennial herb, often with somewhat woody stems, that typically grows 30–200 cm tall, featuring opposite leaves, small greenish-white flowers in dense spikes, and persistent, spine-tipped bracts. The stem is herbaceous but woody below, erect, branched, cylindrical, solid, angular, hairy, and longitudinally striated, with prominent nodes and internodes that are green but violet or pink at the nodes. The leaves of Achyranthes aspera are simple, short-stalked, and covered with fine hairs.

Native to tropical and subtropical regions, it thrives in disturbed habitats such as open dry areas, grasslands, forest edges, roadsides, and waste places, tolerating a wide range of soils and elevations up to 3,000 m. Widely distributed across Asia, Africa, Australia, and the Americas. It is an invasive species in some areas, including many Pacific Island environments.

1.3 Parts Used and Common Preparations

The plant's parts — root, stem, leaves, flowers, and seeds — are used to manage many ailments. Preparations found across traditional and modern use include:

• Powder (churna), decoction (kadha), liquid extract, or specialised Ayurvedic preparations.
• The root is used in decoctions; Apamarga Kshara — the alkaline extract prepared by incinerating the plant — is administered carefully under physician supervision, especially in Kshara Sutra therapy for fistula-in-ano.
• Fresh juice (swarasa) is extracted from the leaves or roots for respiratory issues.
• The dry plant is burnt in open air and the ash is dissolved in water and processed to prepare a medicine used in minor surgical conditions and for oral administration.
• Topical pastes prepared from fresh leaves, applied externally to wounds, insect stings, and skin conditions.

2. Traditional and Historical Use

2.1 Ayurvedic Tradition (India)

Ayurvedic texts have given great importance to this herbaceous plant. Classical Ayurvedic texts such as the Charaka Samhita named a full chapter after this plant — "Apamarga Tanduliya" — describing the many ways it can be used for treating the human body. It is used in the treatment of cough, bronchitis, and rheumatism, malarial fever, dysentery, asthma, hypertension, and diabetes in Indian folklore. The plant is reported to have several medicinal properties and is used as an emmenagogue, purgative, diuretic, antimalarial, antihyperlipidemic, estrogenic, antileprotic, antispasmodic, cardiotonic, antibacterial, and antiviral agent in traditional systems of medicine.

It is also used for snakebite, hydrophobia, urinary calculi, rabies, influenza, otorrhoea, piles, bronchitis, diarrhea, renal dropsies, gonorrhea, and abdominal pain. The pulp prepared from fresh leaves and flowering spikes of A. aspera has traditionally been applied externally as a home remedy for scorpion stings. The seeds of the plant have been mentioned for use in certain eye conditions, including corneal problems, and are also described in relation to snake or reptile bites.

Classical Ayurvedic texts also recommend the paste of Apamarga (Achyranthes aspera) leaf consumed along with sesame oil for the cure of asrigdara, or excessive menstrual bleeding.

2.2 Siddha and Unani Traditions

In Siddha medicine, Achyranthes aspera, known as "Latjira," is valued for its diuretic, anti-inflammatory, and antipyretic properties. The plant is used to treat urinary disorders, including urinary tract infections and kidney stones. It is also employed in the management of fever, bronchitis, asthma, and other inflammatory conditions. The plant is also an important constituent in the Indian medicinal systems of Unani, Ayurveda, and Siddha.

2.3 African Traditional Medicine

In East African traditional medicine, A. aspera is used for treating a number of ailments. Different parts of the plant are used in treating wounds and ringworm in East Africa and elsewhere. Ailments treated include fever, wounds, arthritis, and insect or snake bites. The plant is also employed in East Africa to manage tonsillitis, head wounds, and ringworm conditions. As in many African countries, traditional medicine is deeply rooted in Ivorian culture, and A. aspera is reputed for its use in the folkloric medicine of the Ivory Coast.

2.4 Other Regions

A. aspera has been used in folk medicine in Australia in the 19th century. It is commonly used by traditional healers in Asian countries for the treatment of dysentery, asthma, hypertension, malarial fever, and diabetes. Its seeds have been utilized as a famine food in desert areas of India.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemistry

So far, 58 important compounds have been isolated and identified from various parts of the plant. These isolated constituents are mainly flavonoids, tannins, terpenoids, saponins, and phytosterols, among others, which possess activities including anti-inflammatory and antimicrobial effects. Several classes of phytochemicals such as saponins, phenolic compounds, flavonoids, alkaloids, steroids, and terpenoids have been reported to occur in this plant.

3.2 Principal Identified Compounds

Secondary metabolites including achyranthine, ecdysterone, oleanolic acid, spinasterol, apigenin, achyrantheric acid, ursolic acid, corrosolic acid, and betaine are particularly important in producing the plant's pharmacological actions.

• Triterpenoid Saponins (Oleanolic Acid Glycosides): The triterpenoid saponins isolated from Achyranthes aspera are mainly saponin derivatives with oleanolic acid (OA) as the aglycone. A total of 39 such compounds have been identified. Three oleanolic acid glycosides have been isolated from the seeds, including α-L-rhamnopyranosyl-(1→4)-(β-D-glucopyranosyluronic acid)-(1→3)-oleanolic acid and related glycosides.
• Ecdysterone (20-Hydroxyecdysone): Ecdysterone was isolated from the whole plant. Currently, seven ketosteroid compounds have been isolated from Achyranthes aspera, primarily including 25R-inokosterone, 25S-inokosterone, and β-ecdysterone.
• Achyranthine: Achyranthine is a water-soluble alkaloid reported to possess pharmacological actions such as dilation of blood vessels, lowering of blood pressure, depression of the heart, and increase in the rate and amplitude of respiration.
• Betaine: Betaine acts as an osmolyte, protecting cells from stress. Betaine is a water-soluble base found in the seeds.
• Phenolic Acids: Bioactive compounds isolated by chromatography include ferulic acid, caffeic acid, oleanolic acid, and ursolic acid. Compounds such as protocatechuic acid, caffeic acid, chlorogenic acid, ferulic acid, and gentisic acid are referred to as powerful antioxidants.
• Flavonoids: The two main flavonoids found in Achyranthes aspera are hyperoside (HYP) and 5,2′-dimethoxy-6-(methoxymethyl)-7-hydroxy-isoflavonol.
• Saponins A and B: Saponins A and B are found in the seeds. Saponin A was identified as D-glucuronic acid; Saponin B was identified as β-D-galactopyranosyl ester of D-glucuronic acid.

3.3 Established Mechanisms of Action

Several mechanisms have been proposed on the basis of in vitro and animal studies:

• Anti-inflammatory: The presence of previously documented anti-inflammatory compounds such as alkaloids, saponins, and oleanolic acid could explain the observed anti-inflammatory activity of A. aspera. Oleanolic acid (OA) at concentrations of 1–10 μM inhibits inflammatory responses triggered by microglia overactivation.
• Antioxidant: The antioxidant activities of A. aspera extracts may derive from phenolic acid compounds rather than other identified compounds.
• Enzyme inhibition (antidiabetic): Modest to moderate inhibitory activity was observed against α-amylase (all extracts) and α-glucosidase (dichloromethane extract only). Network pharmacology analysis also suggested carbonic anhydrase II as a putative target explaining, at least in part, the traditional use of A. aspera preparations as a diuretic and blood-clotting agent.
• Antidiabetic (in vivo mechanism): Experimental evidence in diabetic rats indicated that oral administration of Achyranthes aspera not only reduced hyperglycemia and dyslipidemia but also decreased oxidative stress and enhanced pancreatic insulin protein expression, confirming both its antidiabetic and antilipidemic activities.
• Neuroprotective / Cognitive: The oleanolic acid derivative, oleanolic acid saponin, increases acetylcholine levels and improves cognitive function by inhibiting the activity of acetylcholinesterase (AChE). Oleanolic acid (10 mg/kg) can promote the proliferation and differentiation of neural stem cells to enhance hippocampal neurogenesis, improve cell survival, and achieve neuroprotection and repair, thereby ameliorating amyloid-β-induced cognitive and memory impairment.
• Immunomodulatory: Studies show that A. aspera polysaccharides (ABPS) can markedly enhance the immunomodulatory functions of macrophages, increase the activity of natural killer (NK) cells in immunocompromised mice, and elevate the expression of CD40, CD80, and CD86 on the cell surface, stimulating the activation of T lymphocytes, thereby enhancing humoral immunity and non-specific immunity.
• Anticancer (apoptosis induction): The aqueous extract of Achyranthes aspera suppresses cell proliferation and increases cytotoxicity in a dose- and time-dependent manner in colon cancer cells, with this ability attributed to induction of apoptosis via the mitochondrial-mediated pathway and cell cycle arrest in the S phase in COLO-205 cells.
• Hypotensive (achyranthine): Achyranthine is an alkaloid with known hypotensive (blood pressure-lowering) and antispasmodic effects.
• Saponin-mediated effects: Saponins are glycosidic compounds present in the aerial parts of Achyranthes aspera. These compounds possess expectorant, anti-inflammatory, and immunomodulatory effects.

4. Scientific Evidence by Area of Use

The body of scientific evidence for Achyranthes aspera consists almost entirely of in vitro (cell culture) studies and in vivo animal experiments. As of the most recent published reviews, no well-designed randomized controlled trials (RCTs) in human populations have been identified for any specific indication. All evidence described below is preclinical unless explicitly stated otherwise.

4.1 Anti-inflammatory and Analgesic Activity

A study published on PubMed evaluated the anti-inflammatory activity of aqueous extracts of Achyranthes aspera (AEAA) using both leaf and whole-plant preparations in albino mice with carrageenan-induced left hind paw edema. Both extracts exhibited promising anti-inflammatory activity, attributed to flavonoids, alkaloids, saponins, and triterpenoids. The ED50 log dose was 3.09 and 2.75 for the leaf and whole-plant extracts, respectively, at doses of 1200 mg/kg for the leaf extract and 562 mg/kg body weight for the whole plant.

Extracts of the leaves and aerial parts have shown both peripheral (inflammation-mediated) and central (mediated through inhibition of central pain receptors) analgesic effects in animal pain models. Animal studies used doses of 200 mg/kg and 400 mg/kg of alcoholic extract of roots and leaves in adult male albino rats; the dose of 400 mg/kg leaf extract showed maximum analgesic activity. This evidence is entirely preclinical; no human analgesic trials have been identified.

4.2 Antimicrobial, Antifungal, and Anthelmintic Activity

A peer-reviewed study published in Frontiers in Pharmacology (PMC4655238) investigated leaf extracts of A. aspera collected from two African geographical locations. Leaf extracts collected from Ciaat, Eritrea and Ukulinga, South Africa were evaluated for antibacterial, antifungal, and anthelmintic activities against two gram-negative (E. coli and K. pneumoniae), two gram-positive bacteria (B. subtilis and S. aureus), a filamentous yeast-like fungus (Candida albicans), and a free-living nematode (Caenorhabditis elegans). The water and acetone extracts of the samples collected from Ciaat exhibited good antibacterial, antifungal, and anthelmintic activity (MIC <1 mg/ml).

A compound called 17-pentatriacontanol found in the plant's shoots has shown antifungal properties against certain fungal strains. In a separate in vitro study, physico-chemical parameters of A. aspera revealed the existence of saponins, alkaloids, glycosides, and flavonoids in each extract; the methanolic extract showed strong scavenging effects against the DPPH radical in comparison with the aqueous extract. All antimicrobial evidence to date is from in vitro and animal models; there are no clinical trials in humans.

4.3 Wound Healing Activity

A PMC-published in vivo study (PMC8109023) evaluated solvent fractions of an 80% methanol leaf extract of A. aspera for wound healing and anti-inflammatory activities in rats. The methanol extract was fractionated with chloroform, n-butanol, and water. Wound healing and anti-inflammatory activities were evaluated using excision and incision wound models, rat paw edema, and cotton pellet-induced granuloma models. Fractions were evaluated at 5% and 10% ointments, with nitrofurazone 0.2% ointment as the positive control. These findings justify the use of A. aspera extract for the treatment of bacterial infections and wounds, though the mechanism of action in wound healing remains unclear and further studies are needed.

4.4 Antidiabetic Activity

Several animal-based studies have explored antidiabetic effects. Experimental evidence in diabetic rats indicated that oral administration of Achyranthes aspera not only reduced hyperglycemia and dyslipidemia but also decreased oxidative stress and enhanced pancreatic insulin protein expression, confirming both its antidiabetic and antilipidemic activities. Aqueous extract of A. aspera at 500 mg/kg showed significant reduction in blood glucose and HbA1C levels in animal models. In vitro work published in a 2020 PMC study assessed inhibitory potential against α-glucosidase and α-amylase: the antioxidant activity and enzymatic inhibitory potentials towards key enzymes in type 2 diabetes (α-glucosidase and α-amylase) were assessed, with modest to moderate inhibitory activity observed against α-amylase across all extracts, and against α-glucosidase only for the dichloromethane extract. Overall, the differences in extract type, dose, and treatment duration across studies indicate that more standardized experimental approaches are still needed. No human clinical trials on glycemic control with A. aspera have been identified.

4.5 Diuretic Activity

The diuretic properties of the plant are well known to the natives of India and European physicians. Different parts of the plant form ingredients in many native prescriptions in combination with more active remedies. Achyranthine and potassium salts in the plant promote urination and lower blood pressure in some experimental settings. Network pharmacology analysis suggested carbonic anhydrase II as a putative target for explaining, at least in part, the traditional use of A. aspera preparations as a diuretic and blood-clotting agent. Available evidence for diuretic activity is from animal and traditional use data; human clinical trials are absent.

4.6 Hepatoprotective Activity

Biological investigations have revealed that A. aspera possesses hepatoprotective properties, among others. Oleanolic acid is a triterpenoid compound with hepatoprotective and anti-inflammatory properties. Oleanolic acid (OA) has multiple pharmacological actions including hepatoprotective, anti-inflammatory, antidiabetic, and antiviral effects. Animal models have demonstrated protection against hepatotoxic agents, but no controlled human studies are available.

4.7 Anticancer Activity

A PMC-published study (PMC4225856) investigated root extracts of A. aspera against human colon cancer (COLO-205) cells. The aim was to screen the antitumor effect of ethanolic and aqueous root extracts on the growth of colon cancer COLO-205 cells by testing their cytotoxicity, followed by their effect on clonogenicity, migration, and induction of apoptosis. Mechanisms leading to apoptosis and cell cycle arrest were investigated by expression studies of caspase-9, caspase-3, Bax, Bcl-2, p16, p21, and p27 genes. The aqueous extract suppresses cell proliferation and increases cytotoxicity in a dose- and time-dependent manner in colon cancer cells, attributed to induction of apoptosis via the mitochondrial-mediated pathway and arresting cells in the S phase. However, the exact mechanisms and molecular determinants responsible for the initiation of apoptosis need to be further addressed.

Additional in vitro research has explored the plant's effect on Dalton's Lymphoma and breast cancer models in animals. Despite its promising therapeutic potential, further research is warranted to elucidate the underlying mechanisms of action and evaluate its safety and efficacy for clinical applications. All anticancer evidence is preclinical; no human oncology trials exist.

4.8 Immunomodulatory Activity

Studies show that A. aspera polysaccharides can markedly enhance the immunomodulatory functions of macrophages, increase NK cell activity in immunocompromised mice, stimulate T lymphocyte activation, and thereby enhance humoral and non-specific immunity. This mechanism underlies the proposed ability of Achyranthes aspera to improve neurodegenerative diseases by stimulating the immune system. Evidence is animal and in vitro.

4.9 Neuroprotective and Neurological Activity

A 2024 review published on PMC (PMC12014640) summarized current evidence on A. aspera in neurodegenerative diseases. The oleanolic acid saponin derivative increases acetylcholine levels and improves cognitive function by inhibiting the activity of acetylcholinesterase (AChE). At a dose of 10 mg/kg, oleanolic acid promotes the proliferation and differentiation of neural stem cells to enhance hippocampal neurogenesis, improve cell survival, and thereby achieve neuroprotection and repair, ameliorating amyloid-β-induced cognitive and memory impairment in animal models. Research also suggests that Achyranthes aspera may have seizure-reducing properties by enhancing GABAergic neurotransmission in the brain. All such findings are from animal and cellular models.

4.10 Antifertility and Reproductive Effects

Achyranthes aspera is one of the medicinal plants widely used for fertility control in the local health system of Ethiopia. One of the most notable pharmacological activities is its antifertility effect. Studies have demonstrated that extracts from various parts of the plant exhibit significant reproductive toxicity and abortifacient activity in animal models. Specifically, the whole plant extracts and concentrated fractions have shown the ability to prevent pregnancy in female rats and induce abortions when administered during pregnancy.

In ancient Indian literature, the plant is claimed to possess abortifacient activity. The ethanol extract of the root was found to have spermicidal action in vitro and in vivo. A developmental toxicity study published in PMC (PMC8180308) administered ethanolic leaf extract to gravid Wistar rats at doses of 250, 500, and 1000 mg/kg from gestational days 6–12. On day 12, the number of implantation sites and somites in 1000 mg/kg treated rats were significantly reduced. Importantly, after discontinuation of treatment, all animals were mated, resulting in pregnancy and delivery of normal litters, indicating that the action of the extracts was reversible.

4.11 Antilipidemic / Antiobesity Activity

Animal studies have assessed the plant's effects on lipid metabolism. Different parts of the plant and their active phytoconstituents have been investigated for antilipidemic and anti-obesity efficacy and showed positive results in most of the studies. No human trial data are available.

4.12 Respiratory System Activity

A. aspera has shown a broncho-protective effect in toluene diisocyanate (TDI)-induced occupational asthma in Wistar rats, with assessment of total and differential leucocytes counted in blood and bronchoalveolar (BAL) fluid. Traditional use across multiple systems for asthma, bronchitis, and cough is well documented, but clinical human evidence is lacking.

5. Body Systems Associated

• Inflammatory/Musculoskeletal: Anti-inflammatory and antiarthritic effects documented in animal models; traditional use for rheumatism and arthritis.
• Metabolic/Endocrine: Antidiabetic, antilipidemic, and antiobesity effects in animal studies; traditional use for diabetes management.
• Hepatic: Hepatoprotective activity attributed largely to oleanolic acid; animal and in vitro evidence.
• Immune: Immunomodulatory effects via polysaccharides and saponins; animal and in vitro evidence.
• Neurological: Putative neuroprotective, anxiolytic, anticonvulsant, and anticholinesterase effects; animal and in vitro evidence only.
• Renal/Urinary: Diuretic effects attributed to achyranthine; traditional use for urinary calculi and kidney disorders.
• Reproductive: Abortifacient, antifertility, and emmenagogue properties; animal models; traditional use as a reproductive regulator.
• Respiratory: Broncho-protective and antiasthmatic effects in animal models; traditional use for asthma, bronchitis, and cough.
• Dermatological/Wound: Topical wound healing, antimicrobial, and anti-inflammatory effects; in vitro and animal models; traditional use for skin infections and wounds.
• Gastrointestinal: Traditional use as purgative, laxative, astringent, and digestive; preliminary in vitro evidence for gastroprotection.
• Cardiovascular: Hypotensive effects of achyranthine documented in animal pharmacology.

6. Dosage Forms and Reported Dosages

The following dosages are reported in Ayurvedic practice or in the scientific studies cited above. They are presented as reported, not as recommendations.

• Root decoction: Commonly 30–60 ml per day when prepared traditionally.
• Whole plant powder (churna): 1–3 grams daily as reported in Ayurvedic practice.
• Fresh juice (swarasa): Usually 5–10 ml for respiratory issues in traditional use.
• Animal study doses — anti-inflammatory: 1200 mg/kg for leaf aqueous extract and 562 mg/kg body weight for whole plant aqueous extract, in albino mice.
• Animal study doses — analgesic: 200 mg/kg and 400 mg/kg of alcoholic root/leaf extract, in adult male albino rats.
• Animal study doses — CNS depressant/behavioral: The ethanol extract was given intraperitoneally at a dose of 400 mg/kg in albino mice.
• Animal study doses — antidiabetic: Aqueous extract at 500 mg/kg showed significant reductions in blood glucose and HbA1C in animal models.
• Animal study doses — developmental toxicity: Ethanolic leaf extract was given orally at 250, 500, and 1000 mg/kg from gestational day 6–12.
• Animal study doses — antifertility: Oral administration of ethanol and chloroform root extracts at 200 mg/kg body weight caused a significant increase in uterine weight in immature rats.
• Topical wound healing ointment: Fractions were evaluated at 5% and 10% ointments in rat wound models.
• Apamarga Kshara (alkaline ash extract): Used externally in surgical procedures to treat fistula and as oral medicine for obesity and tumors in Ayurvedic practice.

7. Safety Considerations

7.1 Abortifacient and Antifertility Risk

This is the most clearly documented and evidence-supported safety concern. In mice, abortifacient effects were noted with maximum activity at 50 mg/kg body weight. In a rat developmental toxicity study, the number of implantation sites and somites in 1000 mg/kg treated rats were significantly reduced. The anti-implantation effect of the A. aspera root was found to be 83.3% at a dose of 200 mg/kg body weight in a report on post-coital antifertility activity. While quite beneficial in other respects, Achyranthes aspera has been reported to induce reproductive toxicity and has abortifacient effects, which should be considered during use.

7.2 Spermicidal Activity

The ethanol extract of the root was found to have spermicidal action in both in vitro and in vivo studies. Several studies reveal that the leaf of A. aspera has spermicidal effects, among others.

7.3 General Toxicology

In mice toxicity tests, a single dose of 1000 mg/kg body weight was given. After 1 month animals were autopsied and the organs examined; the drug was nontoxic at this dose. In a chronic toxicity test, 75 mg/kg body weight was given every 21 days. After 6 months of drug treatment, blood and tissue samples were examined, and no toxic effects were observed. Three generations of offspring showed no malformations in teratogenicity testing at 10 and 25 mg/kg in mice. The drug showed no estrogenic, antiestrogenic, or androgenic effects in mice.

7.4 Gastrointestinal Effects at High Doses

Higher doses of Achyranthes aspera can cause vomiting and nausea.

7.5 Reversibility of Antifertility Effects

After discontinuation of treatment in animal studies, all animals were mated, resulting in pregnancy and delivery of normal litters, indicating that the action of the extracts was reversible. However, this reversibility has been established only in animal models.

7.6 Species Specificity of Abortifacient Effects

The abortifacient effect was noted to be species-specific, with no abortifacient effect found in rats (as opposed to mice). This limits direct extrapolation to human risk. No clinical safety studies in pregnant humans are available.

7.7 Populations of Concern

Based on animal study data, the plant is associated with potential risk in:

• Pregnant individuals, based on documented abortifacient effects in animal models.
• Individuals undergoing fertility treatment, due to documented spermicidal and antifertility activity.

7.8 Strength of Evidence — Overall Summary

Despite its promising therapeutic potential, further research is warranted to elucidate the underlying mechanisms of action and to evaluate its safety and efficacy for clinical applications. Though the plant holds a reputed position in Ayurveda, no systematic clinical studies have been established. Most previous investigations have focused on A. aspera grown in India, and there remains a dearth of scientific validation on the A. aspera grown in Africa. The existing body of evidence is substantial at the preclinical level but is fundamentally limited by the near-total absence of human clinical trial data for any indication.

References

• Wikipedia — Achyranthes aspera
• PMC3644760 — Effect of aqueous extracts of Achyranthes aspera Linn. on experimental animal model for inflammation (PubMed Central)
• PMC7221715 — Qualitative Phytochemical Fingerprint and Network Pharmacology Investigation of Achyranthes aspera Linn. Extracts (PubMed Central)
• PMC4655238 — Antimicrobial, Anthelmintic Activities and Characterisation of Functional Phenolic Acids of Achyranthes aspera Linn. (Frontiers in Pharmacology / PubMed Central)
• PMC8109023 — Investigation of Wound Healing and Anti-Inflammatory Activities of Solvent Fractions of 80% Methanol Leaf Extract of Achyranthes aspera L. in Rats (PubMed Central)
• PMC10466642 — In Vitro Antibacterial, Cytotoxicity and Wound Healing Activities of Methanol and Aqueous Extracts from Achyranthes aspera (PubMed Central)
• PMC4225856 — Achyranthes aspera Root Extracts Induce Human Colon Cancer Cell (COLO-205) Death by Triggering the Mitochondrial Apoptosis Pathway and S Phase Cell Cycle Arrest (PubMed Central)
• PMC8180308 — Developmental Toxicity of Ethanolic Extracts of Leaves of Achyranthes aspera, Amaranthaceae in Rat Embryos and Fetuses (PubMed Central)
• PMC2816431 — Estrogenic and Pregnancy Interceptory Effects of Achyranthes aspera Linn. Root (PubMed Central)
• PMC12014640 — Role of Achyranthes aspera in neurodegenerative diseases: current evidence and future directions (PubMed Central)
• PMC12731053 — Herbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action (PubMed Central)
• PubMed 23661870 — Effect of aqueous extracts of Achyranthes aspera Linn. on experimental animal model for inflammation
• PubMed 606650 — Abortifacient principle of Achyranthes aspera Linn
• PubMed 16916302 — Effect of Achyranthes aspera L. on fetal abortion, uterine and pituitary weights, serum lipids and hormones
• ScienceDirect — Achyranthes aspera overview (Pharmacology)
• ScienceDirect — Achyranthes aspera overview (Agricultural and Biological Sciences)
• Journal of Drug Delivery and Therapeutics — Therapeutic and Pharmacological Efficacy of Achyranthes aspera Linn.: An Updated Review
• Journal of Drug Delivery and Therapeutics — A comprehensive review on traditional uses, chemical compositions and pharmacology properties of Achyranthes aspera
• Journal of Pharmaceutical Research International — Phytochemical Profile and Pharmacological Aspects of Achyranthes aspera Linn: An Overview
• World Journal of Biology Pharmacy and Health Sciences — Exploring the therapeutic potential of Achyranthes aspera (2024)
• Biosciences Biotechnology Research Asia — Preliminary Phytochemical, Isolation, Characterization, Antioxidant, and Antimicrobial Activity Assessments of Achyranthes aspera L.
• Scholars Research Library — Achyranthes aspera: An important medicinal plant: A review
• International Journal of Pharmaceutical Sciences and Research — Achyranthes aspera: A Potent Immunostimulating Plant for Traditional Medicine